Home/Filings/4/0001209191-15-024338
4//SEC Filing

Celladon Corp 4

Accession 0001209191-15-024338

CIK 0001305253operating

Filed

Mar 8, 8:00 PM ET

Accepted

Mar 9, 9:03 PM ET

Size

15.9 KB

Accession

0001209191-15-024338

Insider Transaction Report

Form 4
Period: 2015-03-09
ZSEBO KRISZTINA M
DirectorPresident & CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2015-03-09$1.12/sh+41,302$46,25844,427 total
  • Sale

    Common Stock

    2015-03-09$24.81/sh41,302$1,024,7039,754 total
  • Sale

    Common Stock

    2015-03-09$24.71/sh6,629$163,8033,125 total
  • Exercise/Conversion

    Stock option (right to buy)

    2015-03-096,629693,648 total
    Exercise: $8.00From: 2015-01-29Exp: 2024-01-28Common Stock (6,629 underlying)
  • Exercise/Conversion

    Common Stock

    2015-03-09$8.00/sh+6,629$53,03251,056 total
  • Exercise/Conversion

    Stock option (right to buy)

    2015-03-0941,302700,277 total
    Exercise: $1.12From: 2013-01-27Exp: 2022-06-14Common Stock (41,302 underlying)
Footnotes (6)
  • [F1]The amount includes shares purchased under Celladon Corporation's employee stock purchase plan prior to the reported transaction.
  • [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on May 20, 2014.
  • [F3]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $25.60 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F4]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.35 to $25.00 per share, inclusive. The reporting person undertakes to provide to Celladon Corporation, any security holder of Celladon Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F5]25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 27, 2012 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.
  • [F6]25% of the shares subject to the option vested and became exercisable on the one year anniversary of January 29, 2014 (the "Vesting Commencement Date"), and 1/48th of the shares vest in equal monthly installments thereafter, over the remaining three years.

Issuer

Celladon Corp

CIK 0001305253

Entity typeoperating

Related Parties

1
  • filerCIK 0001305253

Filing Metadata

Form type
4
Filed
Mar 8, 8:00 PM ET
Accepted
Mar 9, 9:03 PM ET
Size
15.9 KB